NCT06208423

Brief Summary

This study will evaluate the effect of providing access to GPT-4, a large language model, compared to traditional management decision support tools on performance on case-based management reasoning tasks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
92

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 20, 2023

Completed
8 days until next milestone

Study Start

First participant enrolled

December 28, 2023

Completed
20 days until next milestone

First Posted

Study publicly available on registry

January 17, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 19, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 19, 2024

Completed
Last Updated

September 27, 2024

Status Verified

September 1, 2024

Enrollment Period

4 months

First QC Date

December 20, 2023

Last Update Submit

September 26, 2024

Conditions

Keywords

clinical decision support

Outcome Measures

Primary Outcomes (1)

  • Management Reasoning

    Percent correct (range: 0 to 100) for each case.

    Within one-hour study

Secondary Outcomes (1)

  • Time Spent on Management

    Within one-hour study

Study Arms (2)

GPT-4

ACTIVE COMPARATOR

Group will be given access to GPT-4

Other: GPT-4

Usual Resources

NO INTERVENTION

Group will not be given access to GPT-4 but will be encouraged to use any resources they wish besides large language models (UpToDate, Dynamed, google, etc).

Interventions

GPT-4OTHER

OpenAI's GPT-4 large language model with chat interface.

GPT-4

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Participants must be licensed physicians and have completed at least post-graduate year 2 (PGY2) of medical training.
  • Training in Internal medicine, family medicine, or emergency medicine.

You may not qualify if:

  • Not currently practicing clinically.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University

Palo Alto, California, 94304, United States

Location

Related Publications (2)

  • Goh E, Gallo RJ, Strong E, Weng Y, Kerman H, Freed JA, Cool JA, Kanjee Z, Lane KP, Parsons AS, Ahuja N, Horvitz E, Yang D, Milstein A, Olson APJ, Hom J, Chen JH, Rodman A. GPT-4 assistance for improvement of physician performance on patient care tasks: a randomized controlled trial. Nat Med. 2025 Apr;31(4):1233-1238. doi: 10.1038/s41591-024-03456-y. Epub 2025 Feb 5.

  • Goh E, Gallo R, Strong E, Weng Y, Kerman H, Freed J, Cool JA, Kanjee Z, Lane KP, Parsons AS, Ahuja N, Horvitz E, Yang D, Milstein A, Olson APJ, Hom J, Chen JH, Rodman A. Large Language Model Influence on Management Reasoning: A Randomized Controlled Trial. medRxiv [Preprint]. 2024 Aug 7:2024.08.05.24311485. doi: 10.1101/2024.08.05.24311485.

Study Officials

  • Jonathan H Chen, MD, PhD

    Stanford University

    PRINCIPAL INVESTIGATOR
  • Adam Rodman, MD

    Beth Israel Deaconess Medical Center

    PRINCIPAL INVESTIGATOR
  • Andrew Olson, MD

    University of Minnesota

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The grading of responses will be performed by assessors blinded to participant identity and treatment assignment.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The trial will be designed as a randomized, two-arm, single-blind parallel group study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Medicine

Study Record Dates

First Submitted

December 20, 2023

First Posted

January 17, 2024

Study Start

December 28, 2023

Primary Completion

April 19, 2024

Study Completion

April 19, 2024

Last Updated

September 27, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations